Aug 2026· Journal of clinical practice and research· Vol 48, pp. 411 - 421· 0 citations· 22 references
Medicine
TL;DR
Although specific mRNAs serve as key structural hubs, hsa-miR-378c and hsa-miR-449a emerge as robust independent prognostic biomarkers, providing important insights into TNBC risk stratification and potential targeted therapeutic strategies.
Abstract
Objective This study aimed to comprehensively characterize the transcriptomic and proteomic landscape of ferroptosis-associated mRNAs, miRNAs, and proteins, elucidate subtype-specific regulatory networks, and identify potential prognostic biomarkers in triple-negative breast cancer (TNBC). Materials and Methods Using the TCGA-BRCA cohort for discovery and the METABRIC dataset for validation, we performed differential expression and functional enrichment analyses comparing TNBC and non-TNBC subtypes. An integrated miRNA–mRNA regulatory network was constructed, and multivariable Cox proportional hazards regression analysis was performed to evaluate the prognostic value of the identified biomarkers. Results TNBC exhibited profound transcriptional dysregulation, characterized by the marked upregulation of the iron-sequestering gene FTMT (log2FC=5.60) and downregulation of the iron exporter SLC40A1 (log2FC=-3.13). We identified 197 significantly dysregulated miRNAs, including the overexpressed oncomiR hsa-miR-135b and the suppressed tumor-suppressor miRNA hsa-miR-449a. Functional enrichment analyses consistently highlighted substantial disruptions in iron homeostasis and oxidative stress pathways. Network analysis identified NQO1 and SLC38A1 as central mRNA hubs. Notably, although specific mRNAs, including SLC40A1 and ALOX15, demonstrated prognostic value in univariate analyses, multivariable Cox regression analysis revealed that only hsa-miR-378c and hsa-miR-449a remained significant as independent prognostic factors. Conclusion This multi-omics integration maps the ferroptosis-related regulatory landscape of TNBC. Although specific mRNAs serve as key structural hubs, hsa-miR-378c and hsa-miR-449a emerge as robust independent prognostic biomarkers, providing important insights into TNBC risk stratification and potential targeted therapeutic strategies.
This study integrates multi-omics datasets to identify candidate biomarkers that may influence TNBC progression and modulate therapeutic response and nominate CCND2 and KIF1A as candidate biomarkers and potential therapeutic targets in TNBC.
Roberto Aguilar, Victor Wang, Shane Deng· Journal of Immunology· 0 citations
PANX2 is identified as a ccRCC-relevant suppressor of ferroptosis and supports the involvement of a PANX2-Akt/mTOR-SLC7A11-associated signaling axis in redox homeostasis and tumor progression.
Xing-Lin Li, Yiqi Xiong, Ji-Yin Wang et al.· Frontiers in Immunology· 0 citations
Collectively, m6A-related genes are dysregulated in breast cancer and correlate with patient outcomes, highlighting their biomarker potential, with YTHDF3 warranting in-depth investigation.
Pu Jin, Yue-Tsz Fan· Journal of Visualized Experi...· 0 citations
Background and Aims Dysregulated lipid metabolism contributes to hepatocellular carcinoma (HCC) progression, but the prognostic value and mechanistic roles of lipid metabolism-related long noncoding RNAs (LRLs) remain insufficiently characterized. This study aimed to construct and validate an LRL-based prognostic model...
Li-Xin Liu, Yu-Hao Fan, Hao Zou et al.· Journal of Clinical and Tran...· 0 citations
A robust 4‐MQRG signature comprising ANXA10, BAMBI, AKR1B15, and SPINK1 was established, which revealed that patients classified as high risk had significantly shorter overall survival compared to their low‐risk counterparts, thus offering valuable biomarker support for personalized therapeutic approaches in HCC.
Bin-Bin Li, Li-Jun Zeng, Zhi-Long He et al.· Drug development research (P...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.